{
Sanofi

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-012025-04-012025-04-032025-04-031233221100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-012025-04-012025-04-032025-04-0311133221100
Download SVG
Download PNG
Download CSV
Symbol SNY
Name Sanofi
Currency USD
Sector Health Care
IndustryGroup Pharmaceuticals, Biotechnology & Life Sciences
Industry Pharmaceuticals
Market NASDAQ Global Select
Country France
State
City Paris
Zipcode 75008
Website http://www.sanofi.com
Track all markets on TradingView

AstraZeneca's Enhertu approved for reimbursement in China amid ongoing probe

AstraZeneca’s Enhertu, a leading breast cancer treatment, has been approved for reimbursement by China’s state-run medical insurance, enhancing the company’s sales prospects amid an ongoing investigation involving some senior executives. The drug is one of 91 added to the National Reimbursement Drug List, effective January 1, alongside treatments from Johnson & Johnson, Bristol Myers Squibb, Roche, Sanofi, and Merck for various conditions.
Bloomberg.com
United States Dollar Sanofi Merck & Co., Inc. Bristol-Myers Squibb Company Roche Holding AG AstraZeneca PLC Johnson & Johnson GBR Brian Johnson Show more
Healthcare, News Article
08:22 28.11.2024

frontotemporal dementia market growth trends and future projections 2024 to 2031

The Global Frontotemporal Dementia Market is projected to grow from USD 12.19 billion in 2024 to USD 18.21 billion by 2031, at a CAGR of 5.9%. Key players include Johnson & Johnson, Sanofi S.A., and Eli Lilly, with insights into market trends, competitive landscape, and future growth opportunities detailed in a comprehensive report.
openPR.com
United States Dollar Novartis AG Sanofi Mylan N.V. Merck & Co., Inc. Glaxosmithkline plc Eli Lilly and Company USA Priya Pandey Viju Shah Show more
Healthcare, Market Report
13:42 27.11.2024

Sanofi opens 595 million dollar vaccine facility in Singapore for pandemic readiness

Sanofi has inaugurated a $595 million vaccine facility in Singapore, the only one outside France, designed for rapid adaptability in vaccine production. The Modulus plant can switch between different vaccines in days and will create around 200 jobs, enhancing pandemic preparedness. This facility is part of a broader €900 million investment to develop two new evolutive vaccine facilities globally over five years.
CNBC
Euro Singapore Dollar Sanofi SGP FRA
Technology & Innovation, Press Release
08:56 27.11.2024

anofi invests 600 million in new vaccine plant in singapore

Sanofi has inaugurated a new $600 million plant in Singapore, named Modulus, located in Tuas Biomedical Park. This facility is designed to enhance preparedness for emergencies, including pandemics, and can produce up to four vaccines or biopharmaceuticals simultaneously. It is set to be fully operational by mid-2026 and will create 200 skilled jobs in the region.
bloomberg.com
Singapore Dollar Sanofi SGP
Healthcare, Press Release
08:05 27.11.2024

consumer healthcare market poised for rapid growth driven by digital innovations

The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
EIN News
United States Dollar Perrigo Company plc Cardinal Health, Inc. Johnson & Johnson Church & Dwight Co., Inc. Herbalife Nutrition Ltd. Nestlé S.A. Abbott Laboratories Teva Pharmaceutical Industries Ltd. AstraZeneca PLC DSM Nutritional Products AG Pfizer Inc. Colgate-Palmolive Company AbbVie Inc. Bayer AG BASF SE Glaxosmithkline plc Novartis International AG CVS Health Corporation Boehringer Ingelheim International GmbH Sanofi Amway Corporation Novo Nordisk A/S Ipsen S.A. Bristol-Myers Squibb Company McKesson Corporation Merck & Co., Inc. The Clorox Company Reckitt Benckiser Group plc Cigna Corporation Eli Lilly and Company Brian Johnson Show more
Healthcare, Market Report
00:30 27.11.2024

comprehensive analysis of the animal healthcare market trends and key players

The Animal Healthcare Market is projected to grow significantly from 2024 to 2031, driven by evolving market dynamics and investment opportunities. The comprehensive report analyzes regional markets, competitive landscapes, and key players, providing insights into consumption trends, pricing strategies, and future growth prospects. Key segments include production and companion animals, with a focus on pharmaceuticals, vaccines, and feed additives.
openPR.com
Novartis AG Sanofi DSM Boehringer Ingelheim GmbH Virbac SA Merck & Co., Inc. Zoetis Inc. Bayer AG Cargill Inc. Eli Lilly and Company USA CAN DEU FRA MEX ITA ARG ZAF SAU RUS ARE ISR GBR BRA Alice Mutum Viju Shah Show more
Finance & Economy, Market Report
09:08 25.11.2024

healthcare nanotechnology market poised for rapid growth driven by cancer cases

The healthcare nanotechnology market is projected to grow from $308.03 billion in 2023 to $351.82 billion in 2024, with a CAGR of 14.2%, driven by rising cancer cases and advancements in nanomedicine. By 2028, the market is expected to reach $613.9 billion, fueled by innovations in theranostics and personalized medicine. North America led the market in 2023, highlighting the region's significant role in this expanding field.
openPR.com
United States Dollar Luminex Corporation Sanofi Mallinckrodt plc Abbott Laboratories Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Company Pfizer Inc. Merck & Co., Inc. Johnson & Johnson Inc. Celgene Corporation GE HealthCare Technologies Inc. Show more
Healthcare, Market Report
15:59 22.11.2024

rth america oncology drugs market projected to reach 27.20 billion by 2033

The North America oncology drugs market, valued at USD 10.13 billion in 2023, is projected to grow at a CAGR of 10.38%, reaching USD 27.20 billion by 2033. Key drivers include advances in cancer research, rising cancer prevalence, and increasing demand for personalized medicine, while challenges include high drug costs and stringent regulations. The market is segmented into cytotoxic, targeted, and hormonal drugs, with targeted therapies expected to dominate due to their effectiveness and reduced toxicity.
Spherical Insights
United States Dollar Novartis AG Gilead Sciences, Inc. Sanofi Takeda Pharmaceutical Company Limited Johnson & Johnson Amgen Inc. Bristol-Myers Squibb Company Biogen Inc. AstraZeneca PLC Roche Holding AG Pfizer Inc. Merck & Co., Inc. Celgene Corporation AbbVie Inc. Eli Lilly and Company USA Show more
Healthcare, Market Report
14:29 22.11.2024

global pediatric healthcare market poised for significant growth through 2032

The Global Pediatric Healthcare market is projected to grow from $175.6 billion in 2024 to $290 billion by 2032, with a CAGR of 6.5%. Key players include Abbott, Pfizer, and Merck, focusing on pharmaceuticals, nutrition, medical devices, and vaccines across various applications like hospitals and homecare. The market is expanding rapidly in the Asia-Pacific region, while North America remains the dominant market.
openPR.com
Siemens Healthineers AG Pfizer Inc. Medtronic Johnson & Johnson Danone S.A. Philips Merck & Co., Inc. GlaxoSmithKline Nestlé S.A. The Procter & Gamble Company GE HealthCare Technologies Inc. Reckitt Benckiser Group plc Bristol-Myers Squibb Company Sanofi Boston Scientific Corporation Hoffmann-La Roche AG Abbott Novartis AG Bayer USA IND VNM THA IDN SGP MYS JPN KOR HKG AUS PHL TWN CHN Nidhi Bhawsar Show more
Healthcare, Market Report
17:31 20.11.2024

global equine healthcare market projected to reach 1.81 billion by 2028

The equine healthcare market is projected to grow from $1.34 billion in 2023 to $1.81 billion by 2028, driven by factors such as an aging equine population, increased awareness of animal health, and advancements in healthcare solutions. Key players include Merck, Bayer, and Zoetis, focusing on innovative products like protein-based vaccines. North America remains the largest market, with significant investments in animal healthcare infrastructure supporting this expansion.
EIN News
Merck & Co., Inc. Boehringer Ingelheim KG Zoetis Inc. Bayer AG Sanofi USA Zoetis Inc. Boehringer Ingelheim Bayer AG Sanofi S.A. Merck & Co. Inc. Show more
Healthcare, Market Report
00:30 20.11.2024
Trending
Subcategory
Corporate News Industry Trends Global Trade Developments Stock Market Updates Cryptocurrency Trends Startups & Entrepreneurship Industry Mergers & Acquisitions Inflation and Monetary Impact Supply Chain Management Central Banks and Digital Currencies CEO Changes Workplace Trends Blockchain Infrastructure Development Banking Regulations Central Bank Actions Retail and Consumer Goods Private Equity Deals Global Financial Events Government Economic Policies Crypto Policies and Governance
Countries:
USA CHN IND EGY TWN MYS ARE SGP SAU THA JOR DNK MUS IDN PHL VNM QAT IRQ KWT BHR
Companies:
Apple Inc. Foxconn Technology Co., Ltd. NVIDIA Corporation Nasdaq 100 Jun 25 Boeing Co Airbus SE Amazon.com, Inc. Oracle AI USD AppLovin Corp. Tesmec S.p.A. DeepSeek R1 USD LG Electronics Inc. Tesla, Inc. MARA Holdings, Inc. Cleanspark Inc Citigroup Inc. Vodafone Idea Limited JM Financial Limited Fuse Science, Inc. Arla Foods A.M.B.A.
Currencies:
United States Dollar Euro Chinese Yuan Egyptian Pound
People:
Donald Trump Elon Musk Jerome Powell Torsten Slok Adam Foroughi Karen Kuo Cliff Hou Lai Ching-te Young Liu Augustine Fan Bohan Jiang Tucker Carlson Scott Bessent Sam Abuelsamid Cho Jung-tai Hemal Jain Rinshul Chandra Akriti Chopra Lauren Lin Thomas Jane

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.